Colorado's Psychedelic Future Unfolds: Regulators Host Community Meetings To Shape Industry Rules


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Representatives of the Colorado Natural Medicine Division will host five “listening sessions” throughout September and October to engage stakeholders and inform the public of the rollout process of regulated access regulations to the psychedelics legalization ballot measure, reported Marijuana Moment.

Dominique Mendiola, senior director of the division which is under the Department of Revenue, says community involvement is critical in the development of a natural medicine program “that reflects a diversity of perspectives.” The team’s regulatory experience has shown that a key factor is collaborating with all stakeholders. 

Mendiola says the listening sessions will “provide a platform for all voices to be heard to ensure the adopted framework is balanced and well-informed.”

Although regulators expect to announce further meetings in the coming months, the events so far scheduled will take place in-person and via Zoom on September 5, 12, 22 and 27, and October 3. 

Topics to be discussed include SB 23-290's overview and an intro to the Natural Medicine Division; first and multi-responder training; public education campaigns; testing program; and cultivation and manufacturing practices concerning the legal therapeutic provision of psilocybin and psilocin, and potentially ibogaine, mescaline (not derived from peyote) and DMT.

The meetings will be recorded and open to the public, but in-person attendance is yet to be determined by available space at the Department of Revenue.

Additionally, the 15-member Natural Medicine Advisory Board will also host several meetings throughout Sept. 25.

The news is timely considering that, since Prop. 122’s passing, Colorado has seen the flourishing of a gray market for psilocybin that includes not only the sale of psychedelic-containing products but also tripsitting and therapeutic services (see NPR’s July report with state Senate president Steve Fenberg’s concerns).

If you're following the cannabis industry, our upcoming Cannabis Capital Conference is where you ought to be. Whether to close your deals or just get acquainted with the sector’s best, come join us on Sept. 27-28 in Chicago for our 17th edition! Tickets HERE.

Photo: Benzinga edit with photo by Serrgey75, rybart and fizkes on Shutterstock.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: CannabisNewsPsychedelicsRegulationsEventsMarketsColorado Natural Medicine DivisionColorado PsychedelicsPsychedelic-Assisted Therapies